This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

This study has been completed.
Information provided by (Responsible Party):
Somnarus Inc Identifier:
First received: January 9, 2014
Last updated: April 28, 2017
Last verified: April 2017
The purpose of this study is to evaluate the accuracy of Somnarus diagnostic technology for diagnosis of sleep apnea in human subjects. This includes evaluation of Somnarus technology in Obstructive Sleep Apnea (OSA) and Central Sleep Apnea (CSA), including Cheyne - Stokes respiration (CSR).

Obstructive Sleep Apnea Central Sleep Apnea Mixed Sleep Apnea Cheyne-Stokes Respiration

Study Type: Observational [Patient Registry]
Study Design: Observational Model: Case-Crossover
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: Comparison of the Somnarus Sleep Apnea Diagnostic Technology SomnaPatch With Polysomnography in Sleep Disordered Breathing

Resource links provided by NLM:

Further study details as provided by Somnarus Inc:

Primary Outcome Measures:
  • Apnea-Hypopnea Index [ Time Frame: 1 month ]

Enrollment: 190
Study Start Date: January 2014
Study Completion Date: January 2017
Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)


Ages Eligible for Study:   20 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient who have been diagnosed with sleep disordered breathing (apnea or Cheyne-Stokes respiration)

Inclusion Criteria:

  • Able to understand and sign the informed consent
  • Able to comply with visits and follow ups included in this protocol
  • Ages 20-85 years

Exclusion Criteria:

  • An unstable medical condition, acute or chronic, that in the opinion of the investigator puts the subject at health risks related this trial or interferes with the clinical trial and data collection.
  • Skin rash on the nose or on the maxillary area.
  • A history of skin allergy to medical tape, and hypoallergenic tapes.
  • A history of skin cancer on the nose or on the maxillary area.
  • A history of the base of skull fractures, facial fractures
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02034175

United States, California
Peninsula Sleep Center
Burlingame, California, United States
Sponsors and Collaborators
Somnarus Inc
  More Information

Responsible Party: Somnarus Inc Identifier: NCT02034175     History of Changes
Other Study ID Numbers: SomnaPatch-001
Study First Received: January 9, 2014
Last Updated: April 28, 2017

Keywords provided by Somnarus Inc:

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Sleep Apnea, Central
Cheyne-Stokes Respiration
Respiration Disorders
Respiratory Tract Diseases
Signs and Symptoms, Respiratory
Signs and Symptoms
Sleep Disorders, Intrinsic
Sleep Wake Disorders
Nervous System Diseases processed this record on June 23, 2017